Literature DB >> 20135695

Granulocyte colony stimulating factor in neonatal alloimmune neutropenia: a possible association with induced thrombocytopenia.

Christina Wiedl1, Andrew W Walter.   

Abstract

Neonatal alloimmune neutropenia (NAIN) is a rare cause of congenital neutropenia seen in <1% of births. Significant morbidity, usually infections, may result from this disease. The pathophysiology of NAIN, mediated by maternal antibodies crossing the placenta to destroy fetal cells expressing paternal antigens, is similar to that of neonatal alloimmune thrombocytopenia, as well as Rh/ABO hemolytic disease of the newborn. The use of high-dose granulocyte colony stimulating factor in patients with NAIN may cause a reversible thrombocytopenia in some patients. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20135695     DOI: 10.1002/pbc.22315

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  Filgrastim induced thrombocytopenia.

Authors:  Ghazal Kango; Faysal Haroun
Journal:  BMJ Case Rep       Date:  2020-06-30

Review 2.  Neonatal Immune Incompatibilities between Newborn and Mother.

Authors:  Borros Arneth
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.